Status:
COMPLETED
Study in Patients With COPD
Lead Sponsor:
Dey
Conditions:
COPD
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.
Eligibility Criteria
Inclusion
- History of COPD and cigarette smoking
Exclusion
- Clinical diagnosis of asthma.
- Chest X-ray that is diagnostic of a significant pulmonary disease other than COPD
- Disease of other major organ systems
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00215384
End Date
October 1 2005
Last Update
November 11 2010
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Los Angeles, California, United States, 90025
2
Research Site
Upland, California, United States, 91786
3
Research Site
Denver, Colorado, United States, 80206
4
Research Site
Hines, Illinois, United States, 60141